...
首页> 外文期刊>Journal of Cancer Research and Therapeutics >The significance of prophylactic transarterial chemoembolization after radical resection of small hepatocellular carcinoma: A retrospective analysis
【24h】

The significance of prophylactic transarterial chemoembolization after radical resection of small hepatocellular carcinoma: A retrospective analysis

机译:小肝癌根治术后预防性经动脉化疗栓塞的意义:回顾性分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose: To clarify the necessity of prophylactic transarterial chemoembolization (pTACE) after radical resection for small hepatocellular carcinoma (sHCC) (Materials and Methods: Consecutive 161 patients with sHCC in Zhejiang Cancer Hospital from May 2009 to May 2014 were retrospectively studied. In these patients, 87 patients only received radical resection alone (control group), while other 74 patients received pTACE after radical resection (pTACE group). The overall survival (OS) and recurrence-free survival (RFS) were evaluated by Kaplan–Meier method and the related factors on OS and RFS were analyzed by Cox regression analysis. Results: The median OS for all patients was 33.6 months. The median OS in the pTACE and control group was 34.1 and 33.4 months, respectively (P = 0.508). The 1-, 3-, and 5-year survival rates were 91.9%, 73.4%, and 42.7% in the pTACE group and 93.1%, 77.9%, and 51.4% in the control group, respectively. The median RFS in pTACE and control group was 21.6 and 31.3 months (P = 0.002), respectively. The 1-, 3-, and 5-year RFS rate in pTACE group and control group was 81.0%, 47.4%, and 27.6% and 86.9%, 71.7%, and 49.9%, respectively. Preoperative gamma-glutamyl transferase (GGT) serum level ≥60 U/L (hazard ratio [HR] = 2.603, 95% confidence interval [CI] =1.506–4.501, P = 0.001) and recurrence (HR = 6.034, 95% CI = 2.931–12.421, P = 0.003) were independent prognostic determinants associated with poor prognosis in multivariate analysis. Resection followed by pTACE (HR = 2.046, 95% CI = 1.262–3.319, P = 0.004) and preoperative GGT serum level ≥60 U/L (HR = 1.864, 95% CI = 1.152–3.017, P = 0.011) were independent prognostic factors associated with higher rate of recurrence. Conclusions: Instead of improving the survival time, postoperative pTACE increased the rate of recurrence in sHCC patients. Preoperative GGT serum level ≥60 U/L and recurrence were independent prognostic determinants associated with poor prognosis.
机译:目的:明确小肝细胞癌(sHCC)根治性切除后预防性经动脉化学栓塞术(pTACE)的必要性(方法与方法:回顾性研究2009年5月至2014年5月在浙江省肿瘤医院收治的161例sHCC患者。有87例患者仅接受了根治性切除术(对照组),而其他74例患者接受了根治性切除术(pTACE组)后,通过Kaplan–Meier方法和总生存率(OS)和无复发生存率(RFS)进行了评估结果:所有患者的中位OS为33.6个月,pTACE组和对照组的中位OS分别为34.1和33.4个月(P = 0.508)。 pTACE组的3年,3年和5年生存率分别为91.9%,73.4%和42.7%,对照组为93.1%,77.9%和51.4%。 21.6和分别为31.3个月(P = 0.002)。 pTACE组和对照组的1年,3年和5年RFS发生率分别为81.0%,47.4%和27.6%,86.9%,71.7%和49.9%。术前γ-谷氨酰转移酶(GGT)血清水平≥60U / L(危险比[HR] = 2.603,95%置信区间[CI] = 1.506–4.501,P = 0.001)和复发(HR = 6.034,95%CI = 2.931–12.421,P = 0.003)是与多因素分析中不良预后相关的独立预后决定因素。 pTACE(HR = 2.046,95%CI = 1.262–3.319,P = 0.004)和术前GGT血清水平≥60U / L(HR = 1.864,95%CI = 1.152–3.017,P = 0.011)切除是独立的与较高复发率相关的预后因素。结论:术后pTACE不能改善生存期,而可以提高sHCC患者的复发率。术前GGT≥60U / L和复发是与不良预后相关的独立预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号